{"filing":{"accession_number":"0001493152-26-037575","cik":"0000318306","ticker":"ABEO","company_name":"ABEONA THERAPEUTICS INC.","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226037575/form8-k.htm"},"events":[{"id":27500,"run_id":25070,"accession_number":"0001493152-26-037575","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Abeona Therapeutics' financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release reports net ZEVASKYN revenue of $11.4 million (31% quarter-over-quarter growth), net loss of $(20.2) million, and cash position of $146.8 million as of June 30, 2026, along with condensed consolidated financial statements. This is a standard quarterly earnings disclosure material to investors assessing the company's commercial progress and financial condition.","company_name":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29072,"accession_number":"0001493152-26-037575","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Abeona Therapeutics' financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release reports net ZEVASKYN revenue of $11.4 million (31% quarter-over-quarter growth), net loss of $(20.2) million, and cash position of $146.8 million as of June 30, 2026, along with condensed consolidated financial statements. This is a standard quarterly earnings disclosure material to investors assessing the company's commercial progress and financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:31:37.587548+00:00","company_name":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","filing_date":"2026-08-13"}]}